We developed a novel antibody fragment (Fv) technique for localization and determination of the surface topology of membrane protein complexes by immunogold electron microscopy. Several hybridoma cell lines producing murine monoclonal antibodies (MAbs) raised against bacterial membrane proteins were established. The cDNAs coding for the variable domains of the MAbs were cloned and expressed in Escherichia coli. The engineered Fv fragments served as trifunctional adapter molecules. The Fv fragment binds to the epitope of the membrane protein. The Strep tag fused to the VH chain was used for one-step affinity purification of the Fv fragments. Immunological detection of the membrane protein-bound Fv fragments in electron microscopy was accomplished either via the Strep tag with colloidal goldlabeled streptavidin or via the c-myc tag, which was fused u y 3 . 1995; accepted January 25, 1995 (4A3518) to the VL chain, in combination with the c-myc tag-specific antibody 9E10 and a colloidal gold-labeled secondary antibody. We examined four Fv fragments directed against the cytochrome c oxidase or the ubiquinolqtochrome c oxidoreductase of Paracoccus denitrificans and bacteriorhodopsin of Halobacterium halobium to show that this method is generally applicable. In all cases the Fv fragments showed the same results as their corresponding parent antibodies in electron microscopic immunostaining and other applications. (J Histochem Cytochem 43:607414, 1995) Purple membranes isolated from H. balobium strain S9 using the standard procedure (10) were obtained from Prof. Oesterhelt, Martinsried. Spheroplasts of P denitrificans [ATCC 13543 or G440 (pEG436)I grown in methanol or succinate medium (11) were prepared as described (12).
Introduction
A major development in light microscopy (LM) was the use of fluorescent antibodies to localize the respective epitopes (1) . To take advantage of the much greater resolving power of the electron microscope (EM), the introduction of an electron-dense marker (2) opened immunolabeling to EM. Recently, gold particles as tracers for EM have become increasingly popular (3, 4) . The use of polyclonal antibodies allowed specific immunogold labeling of almost any immunogenic compound in the cell at the molecular level (4) . Often, as a drawback, a limited amount of antisera is available and crossreacting antibodies in the antisera may have to be removed on antigen affinity columns. With the invention of a method to continuously produce monoclonal antibodies (MAbs) of predefined specificity ( 5 ) , a better-defined tool became available. However, there are a number of situations, especially with post-embedding techniques, in which well-characterized polyclonal antibodies may be preferred. The demand for a more precise localization favors the use of antibody fragments (6) , peptides, or ligands. The smallest functional antibody fragment is the monovalent Fv fragment, which consists of the non-covalently associated VH and VL domains (7) . Antibody fragments, such as Fab or Fv fragments, were first produced by limited enzymatic proteolysis. Now the antibody genes of hybridoma cell lines encoding the antigen-binding sites can be cloned and expressed. Alternatively, phage or bacteria expressing antibody fragments (Fab, scFv, or Fv) against any antigen can be isolated from libraries (7) (8) (9) . These antibody fragments can now be genetically engineered, endowed with new properties by gene technology, and produced with recombinant homologous or heterologous expression systems (9) . We describe here the use of engineered multifunctional Fv fragments in immunoelectron microscopy (IEM). We demonstrate the potential of this method on the basis of four Fv fragments binding to one membrane protein [ bacteriorhodopsin (BR); Halobacterium halobium] and two integral multisubunit membrane protein complexes [cytochrome c oxidase (EC 1.9.3.1), ubiquinol-cytochrome c oxidoreductase (EC 1.10.2.2, also known as bcl complex) from Paracoccus denitrificans] by comparison with the parent antibodies.
Monocfonal Antibodies
Several hybridoma cell lines producing MAbs against various membrane proteins were established according to standard procedures (5). MAbs were purified from cell culture supernatants by protein Aor protein G-Sepharose chromatography (Pharmacia; Uppsala. Sweden), depending on the isotype present.
Cfoning ana' Production of Fv Fragments
Cloning, production, purification, and characterization of engineered Fv fragments for E M were performed exactly as described previously (13). Briefly the mRNA coding for the variable domains of the established hybridomaderived MAbs was prepared and transcribed into cDNA. The cDNAs coding for the VL and VH chains of the Fv fragment were amplified by the polymerase chain reaction (RT-PCR or inverse PCR). The PCR fragments were purified from agarose gels, cut with the respective restriction enzymes [PstI (or NsiI), BstEII (VH chain), and SstI, XhoI (VL chain)], and cloned via four-fragment ligation into the synthetic dicistronic operon of pASK68 (13) for sequencing, expression. and production of Fv fragments in E. coli K12 strain JM83 (14) . In plasmid pASK68, the operon is under transcriptional control of the 1F"IG (isopropyl 13-D-thiogalactopyra0side)-inducible lac promoter. Both variable antibody chains of the Fv fragment are preceded by signal sequences to direct secretion to the periplasmic space of E. coli. The sequences coding for the affinity peptides Strep tag and c-myc tag are fused to the 3' side of the VH and VL chains, respectively. Fv fragments used for IEM were purified by Strep tag affinity chromatography from the periplasmic fractions of induced bacteria transformed with pASK58 derivatives (15) .
Efectron Microscopy
Specimen Preparation. Isolated purple membranes from H. halobium were adsorbed onto Formvar-coated grids. Membranes were used either unfixed or after fixation with 2% paraformaldehyde and 0.1% glutaraldehyde or 1% glutaraldehyde alone in PBS (10 mM phosphate-buffered saline, pH 8, 138 mM NaCI, 2.7 mM KCI). For blocking of unreacted aldehyde groups and unspecific binding sites, specimens were sequentially treated with 2% glycine and 0.1% BSA (bovine serum albumin) in PBS. After immunolabeling of the membranes on the grids by the appropriate combination of the primary MAb (22A5. 1 hr) or Fv fragment with the corresponding gold-labeled conjugates, the samples were fixed (10/0 glutaraldehyde in PBS, 10 min), washed with water, and negatively stained with 2% uranyl acetate. In addition, some fixed purple membranes immunostained on grids were shadowed with platinum and carbon (PtlC). Shadowing was performed at an angle of 20" and at p "7 x 10.' Torr (16) .
For determination of the binding site of MAb 22A5 on the plasma membrane of lysed H. halobium cells, a cell suspension was slowly diluted with PBS until the cells began to lyse. A droplet of enriched cell ghosts was adsorbed (30 min) onto polylysine-coated glass slides, fixed with 4% paraformaldehyde and 0.1% glutaraldehyde in PBS containing 1.5 mol/liter NaCl (30 min), and blocked ( 2 % glycine in PBS, 0.1% BSA in PBS, 15 min each). After immunogold labeling of the purple membranes (PM) with the appropriate antibodies (MAb 22A5, 1:lOO dilution of 1 mg/ml stock, 30 min), samples on glass slides were fixed (l0/o glutaraldehyde in PBS, 20 min, 1% os04 in 0.1 mollliter sodium cacodylate buffer, pH 7.4, 10 min), and stained en bloc with 2 % uranyl acetate. The samples were dehydrated by alcohol and infiltrated with Spurt's epoxy resin (17) . A resin block was placed over the sample and polymerized to the glass slide. After polymerization, the resin block with the enclosed probes underneath was removed from the glass by treatment with liquid nitrogen. Thin sections were cut and viewed after staining with lead citrate in a Philips EM 300 or CM 12 EM.
To determine the topological binding sites of MAbs and their Fv fragments directed against the integral inner membrane protein complex ubiquinol-cytochrome c oxidoreductase (MAbs 2D6 and 7D3) and the cytochrome c oxidase (MAb 7E2) of P denitrzjkans, the outer membrane of the gram-negative bacterium was removed using a standard procedure (12) to allow access of antibodies or Fv fragments to the extracellular side of the inner membrane. The spheroplasts were fixed (1% glutaraldehyde in PBS, 1 hr), washed in PBS plus 2% glycine, and adsorbed onto glass slides coated with 0.005% Alcian blue or 0.01% poly-~-lysine (Sigma; Deisenhofen, Germany) for about 1 hr at room temperature. Adsorbed spheroplasts were incubated with the appropriate MAbs or their Fv fragments and processed as described above for analysis by EM.
Immunogold Staining of Membrane Proteins by MAbs or Fv Fragments. Specimens were exposed to appropriately diluted purified primary MAbs (22A5,7E2. 7D3,2D6), purified Fvfragments, or the crude periplasmic fraction of E. col2 clones containing the corresponding Fv fragments. Primary MAbs bound to membrane proteins and MAb 9E10 (Cambridge Research Biochemicals; Northwich, UK) were detected in IEM by a second 10-nm gold-labeled goat anti-mouse antibody (Amersham Buchler; Braunschweig, Germany). For detection of Fv fragments specifically bound to membrane proteins, fragments were labeled either via the carboxy terminal Strep tag of the VH chain by a streptavidin-10-nm gold conjugate (Amersham Buchler) or via the c-myc tag fused to the VL chain of the Fv fragment in combination with the anti-c-myc tag MAb YE10 and a second 10-nm gold-labeled goat anti-mouse antibody.
Results

Immunostaining of Membrane Proteins
On-grid immunogold labeling of membranes andlor preem bedding immunogold staining of membranes and spheroplasts were applied to localize membrane protein epitopes o n bacterial cytoplasmic membrane surfaces (16) . To demonstrate that engineered Fv fragments can be used in IEM in the same ways their parent antibodies, the results using four MAbs directed against three different membrane proteins from two species were compared to the results obtained with the corresponding Fv fragments. The characteristics of the MAbs, such as hybridoma cell line, isotype, and Western blot reactivity, are summarized in Table 1 (sequences, X-ray structures, and binding constants will be published elsewhere). The affinity-purified Fv fragments are shown after SDS-PAGE in Figure 1. MAb 22A5 was employed for on-grid staining of isolated PMs from H. hulobium. This MAb specifically binds to one surface of PMs (Figures 2a and 2b) . The labeling of only one side is evident when the membrane sheet folds over itself, giving the MAb access to both surfaces (Figure 2b and Figure 2a inset). Because it is of interest to know which of the two membrane surfaces became labeled, we first tried to demonstrate the differing surface structures by two different techniques (18) (19) (20) (21) that are commonly used to visualize membrane surface structures, i.e., negative staining and heavy metal, low-angle shadowing. To determine the sidedness of the PM by cracks formed during drying (18) was not possible. However, owing to the immunolabeling technique employed, antibody and buffer materials covered the membranes. Consequently, neither by negative staining nor by PtIC shadowing was it possible to identify the relevant side of the membrane by the side-related specific fine surface relief. Therefore, we performed pre-embedding immunostaining of bacterial cells that had been incubated in a buffer medium with progressively lowered salt concentrations before labeling (22) . By this treatment, according to Stoeckenius and Rowen (22) , the cells first become spherical, lose material from their cell wall, and eventually lyse. Under these conditions, immunogold labeling was observed only when the cells have lysed and the cytoplasmic surface of the plasma membrane becomes accessible for antibody binding (Figures 2e and 2f ). Isolated PMs were also labeled with engineered Fv fragments of MAb 22A5. The Fv fragment binding sites were visualized either by goldlabeled streptavidin (Figure 2c) , or anti-c-myc antibody 9E10 plus a secondary gold-labeled anti-mouse MAb (Figure 2d ). The results obtained with Fv fragments were comparable to that obtained with the parent MAb 22A5, irrespective of the method used (Figures  2a and 2b) . The topological binding sites of the MAbs 7E2, 7D3, 2D6 and their Fv fragments directed against membrane protein complexes of I! denitrzficans were also investigated. The pre-embedding immunostaining method was applied with spheroplasts after removal of the outer membrane of the gram-negative bacterium (12) . Under these conditions, antibody binding was observed only at the periplasmic side of the inner membrane for MAb 7E2 and 7D3 (Figures 3a and 4a ). whereas bacterial cells that still possess their outer membrane did not show any labeling. Therefore, the epitope of cytochrome c oxidase of MAb 7E2 is located on the periplasmic face of the inner bacterial plasma membrane, whereas MAb 7D3 binds to the Rieske iron sulfur protein of the ubiquinolcytochrome c oxidoreductase, also exposed to the periplasmic space. The same labeling pattern was observed when engineered Fv fragments of the parent antibodies were used, detected either by streptavidin-gold labeling (Figures 3b and 4b) or by an anti-c-myc tag antibody BE10 (Figures 3c and 4c) .
No labeling of I! denitrifrcans spheroplasts was observed when MAb 2Db was exposed to the specimen (Figure >a) , suggesting that the epitope is situated on the cytoplasmic membrane side. Hence, we performed labeling of an isolated membrane fraction. Indeed, labeling of thin smooth membrane vesicles, probably "inside out" vesicles derived from the inner plasma membrane, occurred with both the parent MAb (Figure Sa inset) and its Fv fragments (Figures  5b and 5c ).
Discussion
We demonstrate here that Fv fragments can be employed in immunocytochemistry in the same way as whole MAbs to determine the cellular localization and topology of biochemically defined antigens. The results with four MAbs directed against a membrane protein and two membrane protein complexes from two species were compared to the results obtained with the corresponding engineered Fv fragments. In all cases, the Fv fragments showed exactly the same results as their parent antibodies, irrespective of Western blot reactivity and specimen preparation employed. The use of Fv fragments has several advantages. First of all, Fv fragments can be cloned from established hybridoma cell lines (7) or derived from phage display libraries (based on synthetic assembly of VDJ regions, the immunological repertoire of naive, conventionally or genetically immunized animals) (23) and produced cost-efficiently in E. coli (9) . When phage or bacterial libraries are used, only antibody fragments will be produced. Therefore, there is a need to broaden the applications of antibody fragments (e.g., Fv, scFv, dsFv fragments or diabodies) in JEM. Second, the fusion of Strep tag and c-myc tag peptides to the Fv fragments allows use of a set of methods for purification and detection of the fragments. A one-. step affinity purification of the Fv fragments is possible (15) and is at least as efficient as the purification of MAbs on protein A or G columns. Third, once the binding conditions between the peptide tag and its ligand have been established, they can also be applied to other Fv fragments. Finally, the Fv fragments are the smallest antibody fragments that retain the affinity of the whole antibody, and therefore increased spatial resolution can be expected. The overall size of an Fv fragment is about 4 nm x 4 nm x 5 nm, whereas an Fab fragment is approximately 7-8 nm long, and the Y-shaped antibody molecule covers ~1 2 nm (24). Therefore, in some cases, steric hindrance or access to the antigen may be less of a problem when Fv fragments are used in immunolabeling. For the best resolution, antibody fragments conjugated directly to very small gold particles (1 nm) must be used ( 2 5 ) . In principle, it should be possible to couple the Fv fragments directly to nanogold particles or fluorescent labels for cost-efficient routine diagnostic or basic research applications. The complex of an Fv fragment and streptavidin [ 5 nm x 6 nm x 5 nm, tetramer (26)) used in this study is approximately the site of an Fab fragment. Biotinylated proteins can efficiently be blocked by avidin to avoid potential unspecific background labeling, since avidin does not interfere with the Strep tag streptavidin system (15). In addition, purification of the Fv fragments is not necessary, as even with crude E. coli periplasmic extracts containing the enriched Fv fragment no obvious unspecific staining and sufficiently strong labeling were obtained in IEM.
Today it is possible to clone any Fv fragment cDNA from hybridoma cell lines (13) or to derive binding fragments from phage display libraries (23). However, in producing Fv fragments or the recently reviewed diabodies (27) with the functional secretion strategy in E. coli, which can easily be scaled up in fermentors (9) . different yields and, particularly in the case of Fv fragments, varying stability, depending on the amino acid sequence, were observed. Yet all Fv fragments tested in our study performed well in IEM, and also proved excellent in immune complex chromatography (13). To improve the stability of some inherently unstable associated Fv fragments, SCFV (28) or dsFv (29) were designed, but since these molecules are usually refolded from E. coli inclusion bodies, protocols for renaturation and additional purification steps to recover plasts and of a membrane fraction from a I I active molecules are necessary. Alternatively, mammalian expression systems were employed to produce functional molecules (30) that are even glycosylated in some cases (31).
W h e n attention is paid to all details, well-engineered recombinant antibody fragments have t h e potential to reach t h e market, a n d should be considered in IEM for routine and novel applications regarding resolution, high specificity, versatility, a n d cost efficiency.
